Amesite Announces NurseMagic™ Sales Growth for Hospice Care Team with Documentation Solution to Ensure Reimbursements, Reduce Audit Risk for Owners
Amesite (NASDAQ: AMST) announced significant growth in its NurseMagic™ hospice documentation tool adoption. The AI-driven solution addresses critical documentation challenges for hospice care providers, ensuring proper reimbursements and reducing audit risks.
Key highlights include:
- Deal sizes with hospice providers grew by nearly 1,000% over the last three months
- NurseMagic™ sales increased by over 3,000% in the same period
- The platform now supports entire care teams including nurses, clinical professionals, and non-clinical staff
- Specialized hospice notes feature focuses on capturing patient decline documentation
The expansion comes as the hospice care market, currently valued at $31.21 billion, is projected to reach $39.09 billion by 2030 with a 4.61% CAGR. End-of-life care represents 21% of lifetime healthcare costs, making efficient documentation important for market growth.
Amesite (NASDAQ: AMST) ha annunciato una crescita significativa nell'adozione del suo strumento di documentazione per hospice, NurseMagic™. La soluzione basata sull'IA affronta sfide critiche nella documentazione per i fornitori di assistenza hospice, garantendo rimborsi adeguati e riducendo i rischi di audit.
I punti salienti includono:
- Le dimensioni degli accordi con i fornitori di hospice sono cresciute di quasi 1.000% negli ultimi tre mesi
- Le vendite di NurseMagic™ sono aumentate di oltre 3.000% nello stesso periodo
- La piattaforma ora supporta interi team di assistenza, inclusi infermieri, professionisti clinici e personale non clinico
- La funzione di note specializzate per hospice si concentra sulla cattura della documentazione del declino del paziente
L'espansione avviene mentre il mercato dell'assistenza hospice, attualmente valutato 31,21 miliardi di dollari, è previsto raggiungere 39,09 miliardi di dollari entro il 2030 con un CAGR del 4,61%. L'assistenza alla fine della vita rappresenta il 21% dei costi sanitari a vita, rendendo la documentazione efficiente importante per la crescita del mercato.
Amesite (NASDAQ: AMST) anunció un crecimiento significativo en la adopción de su herramienta de documentación para hospicios, NurseMagic™. La solución impulsada por IA aborda los desafíos críticos de documentación para los proveedores de atención de hospicio, asegurando reembolsos adecuados y reduciendo los riesgos de auditoría.
Los aspectos más destacados incluyen:
- El tamaño de los acuerdos con proveedores de hospicio creció casi 1.000% en los últimos tres meses
- Las ventas de NurseMagic™ aumentaron más de 3.000% en el mismo período
- La plataforma ahora apoya a equipos de atención completos, incluidos enfermeras, profesionales clínicos y personal no clínico
- La función de notas especializadas para hospicio se centra en capturar la documentación del declive del paciente
La expansión se produce mientras el mercado de atención de hospicio, actualmente valorado en 31,21 mil millones de dólares, se proyecta que alcanzará 39,09 mil millones de dólares para 2030 con una tasa de crecimiento anual compuesta del 4,61%. La atención al final de la vida representa el 21% de los costos de atención médica a lo largo de la vida, lo que hace que una documentación eficiente sea importante para el crecimiento del mercado.
Amesite (NASDAQ: AMST)는 NurseMagic™ 호스피스 문서화 도구의 채택에서 상당한 성장을 발표했습니다. AI 기반 솔루션은 호스피스 치료 제공자를 위한 중요한 문서화 문제를 해결하여 적절한 환급을 보장하고 감사 위험을 줄입니다.
주요 하이라이트는 다음과 같습니다:
- 호스피스 제공자와의 계약 규모가 지난 3개월 동안 거의 1,000% 증가했습니다
- NurseMagic™ 판매가 같은 기간 동안 3,000% 이상 증가했습니다
- 이 플랫폼은 이제 간호사, 임상 전문가 및 비임상 직원을 포함한 전체 치료 팀을 지원합니다
- 전문 호스피스 노트 기능은 환자의 상태 악화 문서화를 캡처하는 데 중점을 둡니다
이 확장은 현재 312억 1천만 달러로 평가되는 호스피스 치료 시장이 2030년까지 390억 9천만 달러에 이를 것으로 예상되고 연평균 성장률이 4.61%에 이를 것으로 예상되는 가운데 이루어졌습니다. 생애 마지막 치료는 생애 의료비의 21%를 차지하므로 효율적인 문서화가 시장 성장에 중요합니다.
Amesite (NASDAQ: AMST) a annoncé une croissance significative de l'adoption de son outil de documentation pour hospice, NurseMagic™. La solution alimentée par IA répond aux défis critiques de documentation pour les prestataires de soins en hospice, garantissant des remboursements appropriés et réduisant les risques d'audit.
Les points forts incluent:
- Les tailles des contrats avec les prestataires d'hospice ont augmenté de presque 1.000% au cours des trois derniers mois
- Les ventes de NurseMagic™ ont augmenté de plus de 3.000% pendant la même période
- La plateforme prend désormais en charge des équipes de soins complètes, y compris des infirmières, des professionnels cliniques et du personnel non clinique
- La fonctionnalité de notes spécialisées pour hospice se concentre sur la capture de la documentation de déclin du patient
L'expansion intervient alors que le marché des soins en hospice, actuellement évalué à 31,21 milliards de dollars, devrait atteindre 39,09 milliards de dollars d'ici 2030 avec un taux de croissance annuel composé de 4,61%. Les soins de fin de vie représentent 21% des coûts de santé sur la durée de vie, rendant la documentation efficace importante pour la croissance du marché.
Amesite (NASDAQ: AMST) gab ein signifikantes Wachstum bei der Einführung seines Dokumentationstools NurseMagic™ für Hospize bekannt. Die KI-gesteuerte Lösung adressiert kritische Dokumentationsherausforderungen für Hospizdienstleister, sichert angemessene Rückzahlungen und reduziert Auditrisiken.
Wichtige Highlights sind:
- Die Vertragsgrößen mit Hospizanbietern wuchsen in den letzten drei Monaten um fast 1.000%
- Die Verkäufe von NurseMagic™ stiegen im gleichen Zeitraum um über 3.000%
- Die Plattform unterstützt jetzt gesamte Pflege-Teams, einschließlich Pflegekräfte, klinische Fachkräfte und nicht-klinisches Personal
- Die spezialisierte Hospiznotizfunktion konzentriert sich auf die Erfassung der Dokumentation über den Rückgang des Patienten
Die Expansion erfolgt, während der Hospizmarkt, der derzeit auf 31,21 Milliarden Dollar geschätzt wird, voraussichtlich bis 2030 auf 39,09 Milliarden Dollar anwachsen wird, mit einer jährlichen Wachstumsrate von 4,61%. Die End-of-Life-Pflege macht 21% der Gesundheitskosten über das Leben aus, was effiziente Dokumentation für das Marktwachstum wichtig macht.
- NurseMagic™ sales growth of 3,000% in 3 months
- Deal sizes with hospice providers up 1,000%
- Expansion to support entire care teams
- Operating in growing market projected to reach $39.09B by 2030
- Successful launch of automated enterprise sales flow
- None.
Insights
Amesite's announcement showcases impressive sales growth for its NurseMagic™ AI documentation platform in the hospice care segment. The reported
What's particularly compelling is Amesite's solution addresses a direct revenue pain point for hospice providers - ensuring proper documentation of patient decline to secure reimbursements. By focusing on this critical documentation challenge, Amesite has positioned its AI platform as a solution that directly impacts customers' bottom line, creating a clear value proposition that's driving adoption.
The hospice care market represents a strategic growth opportunity, projected to expand from
Amesite's expansion from selling to individual nurses to entire care teams, including non-clinical staff, demonstrates a successful land-and-expand strategy. The transition to web-based enterprise sales appears to be accelerating deal closure and enabling the company to target larger organizations, which should provide more sustainable revenue streams if customer retention remains strong.
Amesite's announcement of
The company's AI solution addresses documentation challenges that directly impact healthcare providers' revenue through reimbursements. This value proposition creates a compelling ROI case for customers, as proper documentation directly translates to captured revenue that would otherwise be lost. This clear financial benefit should support continued sales momentum and potentially higher pricing power.
Strategically, Amesite's expansion to serve entire care teams rather than just individual nurses represents an effective account expansion strategy. By covering the full care continuum within hospice organizations, they're increasing their addressable market and revenue per customer while creating higher switching costs. The shift to enterprise sales targeting larger organizations should improve sales efficiency and potentially lead to more predictable revenue streams.
The hospice market's projected growth to
Amesite's Hospice Documentation Addresses Key Pain in Market: Losses in Reimbursements Due to Deficient Documentation
DETROIT, March 05, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the successful adoption of its hospice documentation tool in NurseMagic™. Hospice Notes in NurseMagic™ now solves the major pain for hospice agencies, organizations and conglomerates: proper documentation of patient decline. Missing documentation means unreimbursed charges – but this risk can be eliminated with use of NurseMagic™’s AI, which assists care providers in assuring fast, accurate documentation.
Amesite reports that over the last three months, deal sizes with hospice providers have grown by nearly 1,
Brandon Owens, VP of Sales at Amesite, said, “Hospice care is a vital and rapidly growing segment for NurseMagic™. We now support entire care teams—including nurses, other clinical professionals, and key non-clinical staff such as social workers and nurse aides. NurseMagic™ sales have grown by over 3,
Sai Nittala, Senior AI Manager at Amesite, said, “We specifically tuned our models to serve the hospice sector with specialized hospice notes, that focus on capturing patient decline. This function is essential for proper documentation and reimbursements, and our customers tell us that this level of detail not only improves compliance but also saves administrative workload, allowing staff to focus on client care.”
Amesite CEO Dr. Ann Marie Sastry said, “Amesite continues to expand our footprint across healthcare with NurseMagic™ into the fast-growing segments that enable the U.S. healthcare system to become more efficient. We entered the market for nurses in three segments, and we continue to rollout capabilities to win more segments, using data from the industry’s largest group of professionals – nurses – to inform and improve our technology, reach and sales.”
End of life care presently comprises
Rapid consumer acceptance and demand for hospice care has resulted in a
Rollout of the expanded hospice capability follows Amesite’s successful launches of Automated Enterprise Sales Flow, Enterprise Sales to Large Franchisees and Paid Consumer Subscriptions as Amesite continues to expand its reach both vertically and horizontally across healthcare.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
ir@amesite.com
Sources
- https://www.debt.org/medical/hospice-costs/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC1361028/
- https://www.grandviewresearch.com/industry-analysis/us-hospice-market
FAQ
How much has Amesite's NurseMagic™ sales grown in hospice care over the last 3 months?
What is the main problem that AMST's NurseMagic™ solves for hospice providers?
What is the projected market size for hospice care by 2030 according to AMST's release?
What percentage of lifetime healthcare costs is spent on end-of-life care according to AMST?
How much have AMST's deal sizes with hospice providers increased recently?
